Clinical Trials of Texas

What Clinical Trials of Texas does

Clinical Trials of Texas (CTT) is a multi-specialty clinical research site operator founded in 2001 and headquartered in San Antonio, Texas. It operates as the founding site of Flourish Research, a nationwide multi-site clinical trial network formed in August 2021 when NMS Capital recapitalized CTT and established Flourish as a platform addressing industry fragmentation in clinical research site operations. The company delivers Phase I-IV clinical trials, including first-in-human and in-patient studies, across therapeutic areas including cardiometabolic, oncology, neuroscience, and infectious disease and vaccines, through 26+ wholly-owned sites across 12 U.S. states.

CTT operates a multi-site clinical research network infrastructure built around patient recruitment, enrollment, and study execution rather than a proprietary software platform. Its technology stack centers on a 400,000+ participant recruitment database, standardized site operations across wholly-owned locations, specialized in-patient facilities for Phase I work, and a network of experienced investigators with deep therapeutic expertise. The company maintains regulatory inspection track record and has accumulated 5,500+ successful trials cumulatively across the network.

The business model is fee-for-service professional services revenue from pharmaceutical sponsors and Contract Research Organizations (CROs) under contract agreements. Pricing is not publicly disclosed and varies by study complexity, therapeutic area, and scope of services. The go-to-market is enterprise field sales targeting pharmaceutical sponsors and CROs globally, with a parallel direct-to-consumer patient recruitment channel segmented by demographic. NMS Capital exited its investment in November 2024, and the current ownership structure following that exit is not disclosed.

Name

Clinical Trials of Texas

Legal name

Clinical Trials of Texas

Website

https://saresearch.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

51–100 employees

Short description

Clinical Trials of Texas is a multi-specialty clinical research site operator and founding member of Flourish Research, a nationwide network of 26+ wholly-owned sites running Phase I-IV trials across cardiometabolic, oncology, neuroscience, and infectious disease for pharmaceutical sponsors and CROs.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Health Services (8000)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industries

Clinical CROs (Phase I–IV) (HLAGAAAA), Clinical Development (Phase I–III Trial Design & Execution) (HLAIALAE), Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts) (HLAGACAC)

Keywords

• Clinical research services
• Clinical trial network
• Patient recruitment services
• Phase I-IV trials
• Contract research organization

Headquarters

HQ city

San Antonio

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Clinical Trial Services: Fee-for-service clinical research services to pharmaceutical sponsors and CROs. Revenue generated from conducting clinical trials across multiple therapeutic areas, including patient recruitment, enrollment, and study execution.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Clinical Trials of Texas, operating as part of Flourish Research, conducts Phase I-IV clinical trials for pharmaceutical sponsors and CROs across a nationwide network of 26+ wholly-owned research sites in 12 U.S. states. The company provides end-to-end clinical research services including patient recruitment, enrollment, in-patient and first-in-human studies, and study execution across cardiometabolic, oncology, neuroscience, infectious disease and vaccines therapeutic areas.

Product overview

Flourish Research is a multi-site clinical trial network platform offering end-to-end clinical research solutions. The portfolio consists of the core Flourish Research Network platform encompassing clinical trial site operations (formerly Clinical Trials of Texas), along with specialized modules for In-Patient Services (Phase I/First-in-Human trials), Phase II-IV trials, and patient recruitment services. The network provides trial execution support for sponsors and CROs through wholly-owned sites, experienced investigators, and access to diverse patient populations nationwide.

Differentiator

Problem solved

Functional benefit

Products and services

• In-Patient Services Early phase clinical trial services including First-in-Human and proof-of-concept studies, with facilities, staff experience, and equipment for Phase I trials, delivered to pharmaceutical sponsors and CROs.
• Phase II-IV Clinical Trials Later phase clinical trial services spanning various demographics and conditions, executed across the Flourish Research network's nationwide locations for pharmaceutical sponsors and CROs.
• Patient Recruitment Services Patient recruitment and enrollment services across multiple therapeutic areas, leveraging the Flourish Research nationwide reach, diverse patient populations, and a 400,000+ participant database to meet sponsor enrollment targets.

Quantifiable outcome

• 97% patient retention rate at Boca Raton location for complex cardiovascular trials
• +1 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Flourish ResearchcoreStrategic or Co-development Partner · 1 August 2021Clinical Trials of Texas was used as the foundation entity for the formation of Flourish Research. NMS Capital's formation of Flourish Research created a nationwide network of clinical research sites with CTT as its initial investment and flagship site.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Peers

• ICON plc:

Broad incumbents

• Medpace Holdings: Medpace is a mid-to-large CRO with a strong reputation in mid-sized, full-service clinical trials including site coordination. It is a broad incumbent competitor for sponsor study awards that might otherwise go to multi-site networks like Flourish Research.
• IQVIA: IQVIA is the world's largest CRO with a fully integrated clinical trial delivery platform including site management services. It is a broad incumbent that competes for the same sponsor and CRO contracts Flourish serves, though its scale and breadth dwarf any independent site network.
• Fortrea (formerly LabCorp Drug Development): Fortrea is a global CRO spun out from LabCorp offering clinical trial site and patient services. It is a broad incumbent with overlapping site-management and patient-recruitment capabilities relative to Flourish Research.

Emerging players

• Acurian (Syneos Health / PatientPoint): Acurian specializes in patient recruitment and retention for clinical trials — a core capability Flourish Research highlights via its 400,000+ participant database. Acurian is an emerging/specialty player that overlaps in the recruitment layer rather than the full site network.
• EmVenio Research: EmVenio Research operates a hybrid multi-site and decentralized clinical trial network targeting diverse and underrepresented patient populations — overlapping with Flourish Research's patient-diversity and community-based site model.

Direct peers

• CenExel Clinical Research: CenExel operates a network of wholly-owned clinical research sites with deep expertise in early-phase and specialty Phase I trials, CNS, and cardiometabolic indications — a near-direct competitor to Flourish Research's multi-site, multi-therapeutic site network model.
• Velocity Clinical Research: Velocity Clinical Research is one of the largest wholly-owned multi-site clinical research site networks in the U.S., operating dozens of integrated sites across therapeutic areas including cardiometabolic, CNS, and infectious disease — directly comparable in business model, sponsor relationships, and Phase II-IV execution to Flourish Research.
• CCRA (Clinical Research Alliance / CenExel affiliate): CCRA is a multi-site clinical research organization operating wholly-owned sites across the U.S. with similar Phase II-IV and patient recruitment focus, providing comparable network-based services to sponsors and CROs.
• ResearchPoint Global (now part of Precision for Medicine): ResearchPoint Global was a multi-region clinical research site network offering Phase I-IV services and patient recruitment across therapeutic areas. It is a direct historical peer in the independent multi-site SMO space.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/clinical-trials-of-texas-inc.
• Xx.com/saresearch
• Facebookfacebook.com/ClinicalTrialsofTexas

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clinical Trials of Texas